Abstract |
The ability of three ultimate matabolites of benzo(a)-pyrene and of 7-bromomethylbenz(a)anthracene to induce 8-azaguanine mutants, sister-chromatid exchanges and chromosome aberrations has been investigated. 7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene was shown to be an extremely efficient inducer of both mutants and sister-chromatid exchanges at 100% survival, whereas its geometrical isomer, 7 beta,8 alpha-dihydroxy-9 beta,10 beta-epoxy-7,8,9,10-tetrahydro-benzo(a)pyrene and benzo(a)pyrene-4,5-oxide were comparatively weak. The potency of this compound, as both a mutagen and a sister-chromatid exchange inducer, gives further evidence that it may be the important carcinogenic metabolite of benzo(a)pyrene. 7-Bromomethylbenz(a)anthracene was a moderate mutagen and inducer of sister chromatid exchanges. Comparisons of the relative potencies of these four chemicals as inducers of both mutations and sister chromatid exchanges have indicated that these two phenomena are not directly related. The induction of sister chromatid exchanges also appears to be independent of the induction of chromosome aberrations.
|
Authors | J R Connell |
Journal | International journal of cancer
(Int J Cancer)
Vol. 24
Issue 4
Pg. 485-9
(Oct 15 1979)
ISSN: 0020-7136 [Print] United States |
PMID | 528071
(Publication Type: Journal Article)
|
Chemical References |
- Benz(a)Anthracenes
- Benzopyrenes
- Epoxy Compounds
- Azaguanine
|
Topics |
- Animals
- Azaguanine
(pharmacology)
- Benz(a)Anthracenes
(pharmacology)
- Benzopyrenes
(pharmacology)
- Cell Line
- Cell Survival
(drug effects)
- Chromosome Aberrations
- Cricetinae
- Crossing Over, Genetic
(drug effects)
- Epoxy Compounds
(pharmacology)
- Mutation
(drug effects)
- Sister Chromatid Exchange
(drug effects)
|